Clinical Trial Update: Omalizumab in Interstitial Cystitis/Bladder Pain Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 trial of omalizumab for interstitial cystitis/painful bladder syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Cystitis
• Painful Bladder Syndrome

Drugs mentioned

• Xolair (omalizumab)

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: Interstitial Cystitis, Painful Bladder Syndrome | Phase 3 | Status: COMPLETED